Gene, Cell and Tissue

Published by: Kowsar

R462Q Mutation in Prostate Cancer Specimens

Akram Seidabadi 1 , Seyedeh Elham Rezatofighi 1 , * , Hossein Motamedi 1 and Iran Rashidi 2
Authors Information
1 Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
2 Department of Pathobiology, Faculty of Medicine, Ahvaz Jundishapour University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Gene, Cell and Tissue: July 01, 2014, 1 (2); e19169
  • Published Online: June 4, 2014
  • Article Type: Research Article
  • Received: March 29, 2014
  • Revised: May 11, 2014
  • Accepted: May 19, 2014
  • DOI: 10.17795/gct-19169

To Cite: Seidabadi A, Rezatofighi S E, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens, Gene Cell Tissue. 2014 ; 1(2):e19169. doi: 10.17795/gct-19169.

Abstract
Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem. 1998; 67: 227-64[DOI][PubMed]
  • 2. Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003; 42(7): 1805-12[DOI][PubMed]
  • 3. Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, et al. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate. 2007; 67(8): 849-54[DOI][PubMed]
  • 4. Li H, Tai BC. RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. Clin Cancer Res. 2006; 12(19): 5713-9[DOI][PubMed]
  • 5. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, et al. Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet. 2002; 71(1): 116-23[DOI][PubMed]
  • 6. Mousavi SM. Toward prostate cancer early detection in Iran. Asian Pac J Cancer Prev. 2009; 10(3): 413-8[PubMed]
  • 7. Karimpur-Zahmatkesh A, Farzaneh F, Pouresmaeili F, Hosseini J, Azarghashb E, Yaghoobi M. A2 allele polymorphism of the CYP17 gene and prostate cancer risk in an iranian population. Asian Pac J Cancer Prev. 2013; 14(2): 1049-52[PubMed]
  • 8. Wiklund F, Jonsson BA, Brookes AJ, Stromqvist L, Adolfsson J, Emanuelsson M, et al. Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res. 2004; 10(21): 7150-6[DOI][PubMed]
  • 9. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A. 2009; 106(38): 16351-6[DOI][PubMed]
  • 10. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002; 50(8): 1005-11[PubMed]
  • 11. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002; 32(4): 581-3[DOI][PubMed]
  • 12. Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate. 2008; 68(4): 354-9[DOI][PubMed]
  • 13. Danielson BP, Ayala GE, Kimata JT. Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis. 2010; 202(10): 1470-7[DOI][PubMed]
  • 14. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, et al. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol. 2008; 43(3): 277-83[DOI][PubMed]
  • 15. Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, Beuten J, et al. Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer. 2010; 10: 326[DOI][PubMed]
  • 16. Chen H, Griffin AR, Wu YQ, Tomsho LP, Zuhlke KA, Lange EM, et al. RNASEL mutations in hereditary prostate cancer. J Med Genet. 2003; 40(3)[PubMed]
  • 17. Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, et al. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep. 2012; 39(3): 2347-53[DOI][PubMed]
  • 18. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, et al. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer. 2005; 92(6): 1159-64[DOI][PubMed]
  • 19. Cybulski C, Wokolorczyk D, Jakubowska A, Gliniewicz B, Sikorski A, Huzarski T, et al. DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int. 2007; 79(1): 44-9[DOI][PubMed]
  • 20. Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, et al. Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis. 2010; 31(9): 1597-603[DOI][PubMed]
  • 21. Larson BT, Magi-Galluzzi C, Casey G, Plummer SJ, Silverman R, Klein EA. Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants. J Urol. 2008; 179(4): 1344-8[DOI][PubMed]
  • 22. Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S, Yamanaka H. Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer. 2003; 89(4): 691-6[DOI][PubMed]
  • 23. Kruger S, Silber AS, Engel C, Gorgens H, Mangold E, Pagenstecher C, et al. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. Lancet Oncol. 2005; 6(8): 566-72[DOI][PubMed]
  • 24. Alvarez-Cubero MJ, Saiz M, Martinez-Gonzalez LJ, Alvarez JC, Lorente JA, Cozar JM. [RNASEL study of genetics of prostate cancer and its relation to clinical staging]. Actas Urol Esp. 2012; 36(5): 306-11[DOI][PubMed]
  • 25. Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, et al. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate. 2008; 68(16): 1790-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments